Figure 3From: Effect of chronic treatment with Rosiglitazone on Leydig cell steroidogenesis in rats: In vivo and ex vivo studiesStAR and P450scc immunocytochemistry; A and C - little labeling was observed in control samples for StAR (A) and P450scc (C) (arrows); B and D - increased labeling of StAR (B) and P450scc (D) was detected in rosiglitazone-treated Leydig cell (arrows); L, Lipid droplets; M, mitocondria; N, nucleus; SER, smooth endoplasmic reticulum; Bars 500 nm.Back to article page